NEW YORK (360Dx) – Under a recent Centers for Disease Control and Prevention contract, Rutgers University is validating PCR and real-time PCR assays that could one day be used by hospitals to quickly identify Candida auris, an emerging multidrug-resistant fungal pathogen.

The pathogen is difficult to identity, often does not respond to antifungal drugs, and causes invasive infections that are often acquired in hospitals and are associated with high mortality in patients.

Get the full story with
360Dx Premium

Only $95 for the
first 90 days*

360Dx Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try 360Dx Premium now.

Already a 360Dx Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.